02666 UNI MEDICAL
- 4.690
- +0.010+0.21%
UNI MEDICAL News
環球醫療：年度報告2023
Global Healthcare (02666.HK) completed the issuance of 500 million yuan of renewable corporate bonds
On April 22, GLONGHUI (02666.HK) announced that China Global Leasing Co., Ltd. (the “Issuer”), a wholly-owned subsidiary of the company, will issue the first renewable corporate bonds in 2024 in China. The issuance of the current corporate bonds was completed in China on April 22, 2024. The total principal amount of the current corporate bonds issued is RMB 500 million. The base period is 3 years from April 22, 2024, and the fixed interest rate is 2.99%. At the end of the agreed base period and at the end of each renewal cycle, the issuer has the right to exercise the right to renew. The issue price is RMB per bond
Genertec Universal Medical Unit to Raise Up to 2 Billion Yuan From Bond Issue
Genertec Universal Medical Group's (HKG:2666) unit China Universal Leasing is looking to raise up to 2 billion yuan from the issue of renewable corporate bonds in China, a Wednesday filing on the Hong
Global Healthcare (02666) subsidiary plans to issue renewable corporate bonds of no more than 500 million yuan
Global Healthcare (02666) announced that China Global Leasing Co., Ltd. (issuer), a wholly-owned subsidiary of the company...
China Post Securities: Endogenous growth is steady, and the Hong Kong stock healthcare services sector's valuation is highly attractive
Judging from the overall performance of medical service targets in Hong Kong stocks, with the exception of ICL's high revenue base in the early COVID-19 period, where dental revenue was affected by dental implant collection, most of the revenue from other medical service targets increased relatively well.
Benign Growth For Genertec Universal Medical Group Company Limited (HKG:2666) Underpins Its Share Price
When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") above 10x, you may consider Genertec Universal Medical Group Company Limited (HKG:2666) as a highly attractive
Genertec Universal Medical Group Clocks 7% Rise in 2023 Profit
Genertec Universal Medical Group's (HKG:2666) attributable net profit rose 7% in 2023 to 2.02 billion yuan from 1.89 billion yuan in 2022, according to a Hong Kong bourse filing on Wednesday. Earnings
[Hong Kong Stock Connect] Global Healthcare (02666)'s profit increased 7% last year to $2,021 billion, and plans to distribute a final dividend of HK$0.35 per share
Jinwu Financial News | Global Healthcare (02666) announced that for the year ended December 31, 2023, the company's common equity holders should account for the annual profit of about RMB 2,021 billion (RMB, same below), an increase of 7.0% over the previous year; basic earnings per share were 1.07 yuan, compared with 1 yuan for the same period last year. A proposed final dividend of HK$0.35 per common share. During the period, revenue was approximately RMB 13.65 billion, an increase of 13.1% over the previous year. Among them, the healthcare business revenue was about 7.833 billion yuan, an increase of 22.9% over 2022, and the share of total revenue increased to 57.4%. During the period, the company achieved gross profit of 4
Global Healthcare (02666) Announces 2023 Annual Results Profit attributable to shareholders of 2,021 billion yuan, an increase of 7% year-on-year
Global Healthcare (02666) announced its annual results for the year ended December 31, 2023. The group achieved revenue of $13.65 billion (RMB, same below) during the period, an increase of 13.1%; profit attributable to shareholders of $2,021 billion, an increase of 7% over the previous year; basic income per share of $1.07; and proposed to pay a final dividend of HK$0.35 per share.
UNI MEDICAL: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Genertec Universal Medical Unit Raises 500 Million Yuan From Bond Issue
Genertec Universal Medical Group (HKG:2666) unit China Universal Leasing has completed the issue of 500 million yuan of corporate bonds in China, a Tuesday filing on the Hong Kong bourse stated. The b
Global Healthcare (02666.HK) completed issuing 500 million yuan of corporate bonds in China
On March 25, Global Healthcare (02666.HK) announced that China Global Leasing Co., Ltd. (the “issuer”), a wholly-owned subsidiary of the company concerned, will publicly issue the third installment of the 2024 corporate bonds in China. The issuance of this corporate bond was completed in China on March 25, 2024. The total principal amount of the final issuance of this issue of corporate bonds was RMB 500 million. The basic period is five years from March 25, 2024 (with issuer redemption options, adjustment of coupon interest rate options, and investors' resale options at the end of the 3rd year and the end of the 4th year), with a fixed interest rate of 2.85%. The release price is per person
Genertec Universal Medical Arm to Sell Bonds Worth 1 Billion Yuan
Genertec Universal Medical Group (HKG:2666) subsidiary China Universal Leasing will sell domestic bonds worth 1 billion yuan, according to a Wednesday filing with the Hong Kong bourse. The five-year b
Hong Kong Stock Concept Tracking | Policies Promote Large-scale Equipment Renewal Agencies to Pay Attention to Medical Equipment Procurement Needs (with concept stocks)
On March 1, the Executive Meeting of the State Council reviewed and approved the “Action Plan to Promote Large-scale Equipment Renewal and Trade-in of Consumer Goods”, which proposed “promoting the orderly upgrading of equipment, transportation equipment, and old agricultural machinery, education and medical equipment in key industries.” The equipment update focuses on the field of “building diplomatic relations between workers and agriculture, education, culture and medicine”. The investment scale was about 6 trillion yuan in '27, with an additional investment of about 300 billion dollars every year, focusing on key industries such as metals, chemicals, building materials, electricity, machinery, transportation, textiles, and electronics. Financial support includes subsidies, tax incentives, and reloan interest rates. According to “Chinese Medical Devices
Global Healthcare (02666.HK) held a board meeting on March 27 to consider and approve the annual results
Glonghui, March 11 | Global Healthcare (02666.HK) announced that it is planning to hold a board meeting on March 27, 2024 (Wednesday) to consider and approve (among other things) the Group's annual results for the year ended 31 December 2023, and the proposed final dividend (if any).
UNI MEDICAL: DATE OF BOARD MEETING
Genertec Universal Unit Issues 1 Billion Yuan Bonds in China
Genertec Universal Medical Group (HKG:2666) unit China Universal Leasing has completed the issue of 1 billion yuan worth of bonds in China. The debt securities have an interest rate of 2.65% per annum
Global Healthcare (02666) subsidiary completes issuance of 1 billion yuan of corporate bonds
Global Healthcare (02666) announced that China Global Leasing Co., Ltd., a wholly-owned subsidiary of the company, publicly distributed it in China...
Genertec Universal Unit to Sell Up to 1 Billion Yuan Bonds in China
Genertec Universal Medical Group (HKG:2666) subsidiary China Universal Leasing is preparing to sell up to 1 billion yuan of bonds in China. The debt securities will mature in five years, the healthcar
Global Healthcare (02666.HK) Affiliated to the Public Issuance of Corporate Bonds in China (Phase II)
Gelonghui, Feb. 27丨Global Healthcare (02666.HK) announced that China Global Leasing Co., Ltd. (the “issuer”), a wholly-owned subsidiary of the company, has received approval from the China Securities Regulatory Commission to publicly issue domestic public corporate bonds with a total principal amount of up to RMB 8 billion to qualified investors in China. As of the date of this announcement, the remaining amount of the company's bonds was RMB 2.6 billion. The company's bonds are issued in installments. The total principal amount issued by the issuer in 2024 for the second installment of corporate bonds shall not exceed RMB 1 billion (including RMB 1 billion), with a base period of five years, with the end of the second and third years
Analysis
Price Target
No Data
